chrisvoncsefalvay/vaers-outcomes huggingface dataset:
JOINT PAIN-ALL JOINTS (ALTHRALGIA, ARTHRALGIA). JOINT STIFFNESS/JOINT DISORDER. PAIN AT SITE OF INJECTION. SWELLING AT SITE OF INJECTION. INJECTION SITE EDEMA. A report was received from a health care professional on 28 October 2003 concerning a 39 year old female vaccinee who experienced pain and swelling at the site of injection on the same day of receiving Fluvirin and pain in all of her joints and joint stiffness 2 days after receiving Fluvirin on 23 October 2003. On 23 October 2003, the vaccinee experienced pain and swelling at the site of inject on which continued until the next day. On 25 October 2003, the vaccinee experienced pain in all her joints (including her toes), and joint stiffness. The reporter indicated that the vaccinee has received influenza vaccines annually for the past 11 years and has not experienced this type of adverse reaction. At the time of reporting the vaccines had not recovered. The vaccinee plans to be evaluated by her physician. There was insufficient information to determine the reporter's causality assessment. Update 1, 09 January 2004: Futher information was received from a health care professsional indicating that the vaccinee experienced joint pain ina ll her joints on 24 October 2003 after receiving Flurin on 22 October 2003. The joint pain made it difficult for the vaccinee to move. The vaccinee had no relief despite treatment with ibuprofen following one week without improvement and off work the vaccinee consulted her physician who prescribed 40 mg daily of prednisone for 5 days. The vaccinee started to improve within 2 days. However, two weeks later the vaccinee still had some joint pain in her arms, shoulders and hands. The vaccinee recovered in an unspecified date The reporter has asssesed the relationship of the vaccine to the joint pain as probable. Update 2, 07 April 2001: Following medical review this case was upgraded to serious in view of the nature and persistence of the joint pain and stiffness, the lack of response to NSAID and the requirement for prednisoe. Follow up pending.  Follow up on 07/19/04 states: "The reporter confirms that the joint pain and stiffness started on 10/23/03 and had resolved by 12/01/03. The vaccinee had consulted her physician, has stayed off work for one week and had taken corticosteroids to decrease the pain. She had received influenza vaccines previously, but had not experienced any problems before. The reporter considers the events probably related to Fluvirin. No further information is expected."
I have had a fever ranging from 100.1 to 100.5 since 7 pm on the day I received the 2nd dose vaccine on 1/4/2021. Symptoms include extreme body aches, joint aches, and headache. Today is 1/6/2021 my temp at 7:30 am was 100.3. I have had to miss work yesterday and today so far.
Injection site reaction beginning just after 24 hours post injection.  Painful, red, blotchy, raised/swollen upper left arm. Symptoms did not occur with first dose. Symptom remains the same as I submit this summary; 36hours post vaccine.  Other symptoms experienced between 12-24 hrs after second shot only included fever of 102 degrees, body aches/chills, extreme muscle weakness, fatigue, headache and nausea.
Severe Migraine; fatigue; feeling feverish; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced severe migraine, fatigue, and feeling feverish still, more than 10 days after. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events severe migraine, fatigue, and feeling feverish was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Shot on 3/10/2021;  'asthmatic' breathing issues began within 2 hours. Began 40 mg of prednisone and ventolin inhaler within 12 hours of shot. 3 days later prednisone increased to 60 mg and DuoMed nebulizer was added. Xray was done and showed bibiphasal atelectasis so 750 mg. Leviquin was started. Lung function tests at pulmonologist showed poor lung function over the course of 2.5 months following the first dose of the Pfizer vaccine. 1 ER visit for O2 Sats at 88%. I went from walking 6 miles 4 days before shot to using 7 rescue inhalers in 3 months, plus 1 maint inhaler, 2 rounds of prednisone, 2 rounds of antibiotics and 2 nebulizer medications just to be able to breathe/talk. As of today, I require all meds.
Pt had been vaccinated yrs ago with the pneumococcal vaccine 23 polyvalent. On 08/03/00, the pt presented to a physician complaining af arthritis and pain. It was noted that the pt insists that these symptoms occurred only after being vaccinated. The physician indicated that the pt was seen by several other specialists such as rheumatologists, radiologists, and other specialists who all concur that the test performed do not indicate rheumatoid arthritis. Additional information has been requested.
30 min post vaccination while at end of  observation period,  ct felt pressure at top/side of head, tightness in front and side of throat, felt trouble swallowing . Observation of ct mouth/tongue by attending RN, indicated no obvious swelling, airway clear to oscultation balaterally throughout. Ct waited in observation area for an additional 30min, after which time she felt the sesations of tightness in her head and throat dissipating, 'not getting worse', left clinic with her mother, recommended to stay in town for another 30min before heading back home. Ct said they stayed in town a few hours, stated her arm got sore, increase in headache, 'that was it, went well'.
pt recv vax 10NOV95 & 1MAY97 pt devel chickenpox;mom reported chickenpox looked like mosquito bites;rash consisted of red marks w/no pus;pt to MD 2MAY97;
Tested positive for Covid; Tested positive for Covid; This is a spontaneous report received from contactable reporter(s) (Consumer), Program ID: (172086). The reporter is the patient. A 65-year-old female patient received BNT162b2 (BNT162B2), on 03Mar2021 as dose 1, single (Lot number: EN6204), on 23Mar2021 as dose 2, single (Lot number: EP6955) and on 02Dec2021 as dose 3 (booster), single (Lot number: FE3590) at the age of 64 years for COVID-19 immunization. The patient's relevant medical history included: "long Covid", start date: Jun2020 (unspecified if ongoing); "COVID-19" (unspecified if ongoing). Concomitant medication(s) included: ESTRADIOL TRANSDERMAL. It was mentioned that the patient has been healthy as a horse before this. The patient had COVID-19 the first time before the vaccine was out and had long COVID-19 back then too. In 2022, the patient was tested for the flu and strep (unknown results). It was thought that she had strep because her throat was hurting so bad but was tested positive for COVID-19 (vaccination failure) in Jul2022 at the office and on her home test. Two days earlier in 2022, she was negative on the home COVID-19 test. The patient started PAXLOVID (NDC number: 0069-1085-30) from 02Jul2022 until 06Jul2022 as treatment for COVID-19. Outcome of the events were unknown.
IV administration of Fluarix to a patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administered by other route in a 66-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2022-2023 season) (batch number 5KT78, expiry date 30-JUN-2024) for prophylaxis.   On 20-OCT-2023, the patient received Fluarix Quadrivalent 2022-2023 season (intravenous). On 20-OCT-2023, an unknown time after receiving Fluarix Quadrivalent 2022-2023 season, the patient experienced intramuscular formulation administered by other route (Verbatim: IV administration of Fluarix to a patient). The outcome of the intramuscular formulation administered by other route was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 20-Oct-2023 The reporter consented to follow-up. The patient received Fluarix quadrivalent intravenously, which led to intramuscular formulation administered by other route.
This is in follow-up to report (s) previously submitted on 1/16/2009. Information has been received from a physician concerning a patient who on an unknown date was vaccinated with a dose of GARDASIL, (site, route and lot no. not reported). The patient experienced bipolar aphthosis. This is one of several reports from the same source. Additional information has been requested. Follow up information was received from the physician was reported that she did not give the vaccine and that she has no information about the shots. This is one of several reports from the same source. No further information is available.
PATIENT HAD MMR AND VARICELLA ON 09/01/10. CHILD RAN LOW GRADE FEVER FOR THREE DAYS PRIOR TO BREAKING OUT WITH A RASH ON 9/17/2010. WAS GIVEN BENADRYL LIQUID BY GRANDPARENTS. PATIENT'S MOTHER DELIVERED A BABY ON 9/14/2010. PATIENT WAS OUT RIDING ON 4 WHEELER. NOT REAL SURE IF SHOTS CAUSED REACTION SINCE IT WAS 16 DAYS AFTER SHOTS THAT THE RASH OCCURED. CHILD WAS NOT AROUND NEWBORN WHEN SHE HAD FEVER. CHILD IS OKAY NOW.
Dizziness, Fever, NauseaVomiting, chills Narrative:  missed a day of work
Information has been received from a nurse practitioner concerning a 65 year old female patient who, about 5 years ago, in approximately 2007, was vaccinated with a first 0.5 ml dose of PNEUMOVAX 23 (route and lot # not reported). About 2 weeks ago, on approximately 02-MAR-2012, the patient experienced "an injection site reaction, cellulitis, after receiving a booster of PNEUMOVAX 23". The patient was treated with "unspecified antibiotics and an unspecified pain medication". The patient was recovering from the events at the time of reporting. The patient sought unspecified medical attention. Follow up information has been received from a nurse practitioner concerning the 65 year old retired female patient (weight 105.6, height 64) with Sulfa allergy who on 13-MAR-2012 (also reported as 03-MAR-2012) was vaccinated IM with a dose of PNEUMOVAX 23 (lot # 672781/1706AA, dose not reported) in the left deltoid at a community center. The patient had no illness at time of vaccination. That evening on 13-MAR-2012, she developed redness and swelling at injection site. By the time the reporter evaluated her on 14-MAR-2012, the redness, swelling and induration had spread to involve most of her upper arm. For cellulitis, she received ceftriaxone IM and was prescribed doxycycline. The patient required emergency room/doctor visit. The patient recovered from the events on 16-MAR-2012. The events were considered to be other important medical events by the reporter. Additional information has been requested.
red rash and swelling at injection site.  increased redness and swelling when became heated after exercise
pt had URI morning of clinic appt; mom reported no fever only cough; pt given vax; p/left clinic parents decided to take pt to local hosp-upon exam found to have otitis media tx Amoxicillin & Rondec; t100.3
Found limp & blue; father put pt to bed for a nap checked on pt 15 mins later unconcious; father is EMT & sucessfully resusciatated pt; pt is well now;
Pt received DTaP but should have received Tdap. Per Health Department, it is okay that the patient received DTaP and will still count towards Tdap.
Patient experienced an allergic reaction that consisted of a rash that was on her ankles and spreading up her legs, on her arms, and on her cheeks.  She described the rash as very itchy.
p/vax pt had some staring spells; excessive startle reflex during sleep x24 hours;
couldn't go to work; couldn't walk; red and swollen legs from the knee to her buttock; could not even stand up to go to the bathroom; joints of her toes, of her ankle, she was sore; as if they were inflamed; Did not want to take second shot; flesh of his legs felt like "snoring"; hands swollen; hands hot; hands hard; she is bad; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (hands swollen), FEELING HOT (hands hot), MUSCULOSKELETAL STIFFNESS (hands hard), MALAISE (she is bad) and IMPAIRED WORK ABILITY (couldn't go to work) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes. Concomitant products included METFORMIN for Diabetes.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PERIPHERAL SWELLING (hands swollen), FEELING HOT (hands hot), MUSCULOSKELETAL STIFFNESS (hands hard) and MALAISE (she is bad). On an unknown date, the patient experienced IMPAIRED WORK ABILITY (couldn't go to work), GAIT DISTURBANCE (couldn't walk), PERIPHERAL SWELLING (red and swollen legs from the knee to her buttock), DYSSTASIA (could not even stand up to go to the bathroom), PAIN (joints of her toes, of her ankle, she was sore), INFLAMMATION (as if they were inflamed), INTENTIONAL DOSE OMISSION (Did not want to take second shot) and MYALGIA (flesh of his legs felt like "snoring"). At the time of the report, PERIPHERAL SWELLING (hands swollen), FEELING HOT (hands hot), MUSCULOSKELETAL STIFFNESS (hands hard), MALAISE (she is bad), IMPAIRED WORK ABILITY (couldn't go to work), GAIT DISTURBANCE (couldn't walk), PERIPHERAL SWELLING (red and swollen legs from the knee to her buttock), DYSSTASIA (could not even stand up to go to the bathroom), PAIN (joints of her toes, of her ankle, she was sore), INFLAMMATION (as if they were inflamed), INTENTIONAL DOSE OMISSION (Did not want to take second shot) and MYALGIA (flesh of his legs felt like "snoring") outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) She has been tested 8 times for COVID-19 and was negative every time.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: TCR added, new event added and patient denied follow up
pt recvd vax; forgetful & could not concentrate; lasted 3 days p/ 2nd dose; 31may94 f/u:very tired for 5 days p/ dose 2;local rxn p/ both doses;rabies titer 1:50 28apr94;
Received vaccine late PM on 11/15/10. Approx. 9pm throat felt raspy (3:30am) rapid pulse, tightness in lungs, headache and felt extremely hot.
Received MMR about 2pm 12/08/05.  About 1- 1.5 hours later began to have symptoms-palpitations, numbness extremities, vomited twice.  Dizzy.  Symptoms lasted about 3 hours.  Feels fine now.
Patient experienced expected fatigue, body aches, fever, chills for 4 days.  On day 4 Patient started having intense intrusive suicidal thoughts which made him tearful because he reportedly said he did not want to commit suicide but could not get the thoughts out of his head. Suicidal ideation, agitation, crying and inability to complete ADL's continued until patient was able to receive a ketamine infusion on late evening 9/18/21. He was seen by his PCP on 9/20/21
Chest pain, not radiating, difficulty moving. Got checked out at a local ER and ruled out major events.
Lt arm swollen fr shoulder to elbow. Hot to touch, skin taut, bruising @ inject site. Warm to touch on forehead - no temp taken given Tylenol & cold applications.  Had full use of arm.
8 patients got expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine). On 28-Sep-2021, EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Low grade fever started around midnight, gave Tylenol at 5 AM when fever was 100.0F. Vomiting throughout the day, crying all day, when not crying, he was sleeping.  Had a suspected seizure about 2 pm (staring into space, stiff body, for 5-10 seconds.)
baby (4 month) have any protection after one dose/We made it in 3 month; This case was reported by a consumer via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-month-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The case was reported by patient's parent. The patient received dose of bexsero at the age of 3 months, which led to inappropriate age at vaccine administration. The reporter inquired that was the patient had any protection after one dose. The follow up would not possible as no contact details were available.
10/15/21 (day of shot): 9pm - left side chest pain and headaches. Chest pain has been continuous since 10/15/21 but the severity has differed. 10/16 & 10/17: episodes of severe stabbing chest pain. 10/17: went to ER and they confirmed inflammation in or around heart, given Ibuprofen 600mg. Ibuprofen alleviated the pain until it would wear off. 10/18: contact PCP Dr.: she advised to continue Ibuprofen and contact her if not better by day 10.  10/18-10/22: I experienced episodes of lightheadedness while sitting at my desk working. These episodes were severe to the point I thought I'd blackout and lasted 30 min or so.  On 10/25 I contacted Dr. as the chest pain had not gotten better and had in fact gotten worse because the ibuprofen was no longer effectively addressing the pain.  She prescribed prednisone that I'm currently taking.
This spontaneous report as received from a pharmacy technician refers to a 60 year old patient (gender unknown). No information regarding the patient's medical history was provided. Or an unknown date the patient was vaccinated with VARIVAX (Merck) instead of ZOSTAVAX. No concomitant medication was reported. No adverse effects were reported. No outcome was reported. Additional information is not expected.
within minutes she developed palpitations that lasted < 1 hour and numbness/tingling in the left arm (opposite the injection arm) that traveled along the ulnar nerve into the hand. This resolved after a few hours. She also developed dizziness within minutes that resolved but has been intermittent since the injection.  She also has bilateral facial parasethesias involving the lower face that is intermittent since the vaccine
01/28/22 presents to ED for "palpitations". PMHx of "DM, obesity"
Sweating and soaked clothes; Increase blood sugar; very bad muscle pain; very bad Joint  pain; chills; Swollen in the arm and fingers; Nauseated; This is a spontaneous report from a contactable pharmacist. A 52-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via intramuscular in the left arm on 20Mar2021, as a single dose for COVID-19 immunisation. The patient did not have medical history. The patient was allergic to codeine. Concomitant medications included vitamin c (MANUFACTURER UNKNOWN) and vitamin d (MANUFACTURER UNKNOWN) from unspecified date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via intramuscular in the left arm on 28Feb2021, as a single dose for COVID-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient underwent blood sugar test and result was found to be increased. On 21Mar2021, the patient experienced chills, increased blood sugar, nauseated, sweating and soaked clothes, swollen in the arm and fingers, very bad joint pain and muscle pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The treatment for the reported events included hot shower, applied voltaren, eating lemon, drinking ginger tea, and ultramarine between ibuprofen. The clinical outcome of the events chills, increased blood sugar, nauseated, sweating and soaked clothes, swollen in the arm and fingers, very bad joint pain and muscle pain were recovering at time of this report.  Information about lot number cannot be obtained. No further information is expected.
My menstrual periods had changed since the vaccine, I didn't fill up a form until my 3 period came to make sure it was not just a single event, principal changes involve menorrhagia and dysmenorrhea which I have never had before.
left sided facial, ear, and neck paresthesia.  Felt similar to numbness after dental procedure.  Initially felt my ear become hot and then touched it and noticed it felt numb.  Then feeling spread to side of cheek and jaw and down the side of my neck on same side.  Same side as injection.  Onset was about 12-15 minutes after injection, immediately prior to being told it was ok to leave the observation area.  Seems to have resolved almost entirely 1.5 hours after injection, though ear still seems to have slightly abnormal feeling.
My son was telling the nurse how bad the medicine in the shot hurt, when suddenly he went stiff, fell backward, went sheet white for about a minute before waking up very clammy and very pale.   He said he feel asleep when he woke up. He didn't know where he was. The doctor gave him a popsicle and popcorn. Checked his blood pressure. I feed him a big lunch and he's been fine since.  Will NOT be giving him the second dose though. He did eat breakfast but had not had lunch yet.  Our appt was at 11:10. Shot was given around noon.